Enanta Pharmaceuticals (ENTA)
(Delayed Data from NSDQ)
$15.17 USD
+1.26 (9.06%)
Updated May 3, 2024 04:00 PM ET
After-Market: $15.18 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Enanta Pharmaceuticals, Inc. [ENTA]
Reports for Purchase
Showing records 161 - 163 ( 163 total )
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
NASH Weekly Newsletter: NASH News Flow From JP Morgan Healthcare Conference
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Enanta Pharmaceuticals, Inc.
Industry: Medical - Drugs
Agenda for Our First Annual NASH Investor Conference on April 3 in NY
Provider: H.C. Wainwright & Co., Inc.
Analyst: ARCE E